Skip to content

Efficacy of Acupuncture Combined with Transcranial Magnetic Stimulation on Cognitive Function in Remission-phase Schizophrenia and Its Effects on Brain Function: A Resting-state Functional Magnetic Resonance Imaging Study

Efficacy of Acupuncture Combined with Transcranial Magnetic Stimulation on Cognitive Function in Remission-phase Schizophrenia and Its Effects on Brain Function: A Resting-state Functional Magnetic Resonance Imaging Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001322
Enrollment
Unknown
Registered
2025-07-01
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Experimental group:Acupuncture treatment combined with rTMS treatment

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 63 Years

Inclusion criteria

Inclusion criteria: a) The experimental subjects met the diagnostic criteria for schizophrenia in the International Classification of Diseases (ICD-10); b) The total disease course was =2 years; c) No dosage or type of antipsychotic drugs was adjusted within 6 weeks before enrollment and the PANSS scale score was < 60 points; d) No electroconvulsive shock without convulsions (MECT) rTMS or acupuncture treatment has been received in the past half year; e) Right-handed player.

Exclusion criteria

Exclusion criteria: a) Severe epilepsy brain diseases or mental disorders caused by psychoactive substances; b) Those who have serious impulsive acts of destroying property or self-harm or self-mutilation; c) Women who are breastfeeding pregnant or likely to become pregnant during the study period; d) Those with metal foreign bodies built into the skull implanted cardiac pacemakers or cochlear implants; e) The electroencephalogram is significantly abnormal and rTMS cannot be performed;

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment Scale;Functional magnetic resonance;

Secondary

MeasureTime frame
Positive and Negative Symptom Scale;Digit Span Task;Trail Making Test;Mini-mental State Examination;

Countries

China

Contacts

Public ContactZHOU Yongcan

Tongde Hospital of Zhejiang Province

asdas0101@qq.com15157136906

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026